Both in Pharmaceuticals
BeyondSpring vs TransCode Therapeutics
Over the past year BYSI returned −67.6% and RNAZ returned −85.4%; their daily moves had a correlation of 0.07.
BYSI −67.6% RNAZ −85.4%Growth of $1, one year, split-adjusted
| Metric | BYSI | RNAZ |
|---|---|---|
| Price | $0.6438 | $1.63 |
| Market cap | $26.5M | $27.6M |
| Today | +24.60% | −5.78% |
| 1 month | −20.9% | +5.5% |
| 6 months | −56.8% | −79.2% |
| Year to date | −60.5% | −76.1% |
| 1 year | −64.8% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $6.5M | $7.7M |
| Dividend yield | — | — |
| Volatility (60d) | 161.2% | 76.4% |
| Short % of float | 7.5% | 8.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).